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Abstract The most important goal of introducing non-
invasive ventilation (NIV) has been to decrease the need for
intubation and, therefore, mechanical ventilation in
newborns. As a result, this technique may reduce the
incidence of bronchopulmonary dysplasia (BPD). In addi-
tion to nasal CPAP, improvements in sensors and flow
delivery systems have resulted in the introduction of a
variety of other types of NIV. For the optimal application of
these novelties, a thorough physiological knowledge of
mechanics of the respiratory system is necessary. In this
overview, the modern insights of noninvasive respiratory
therapy in newborns are discussed. These aspects include
respiratory support in the delivery room; conventional and
modern nCPAP; humidified, heated, and high-flow nasal
cannula ventilation; and nasal intermittent positive pressure
ventilation. Finally, an algorithm is presented describing
common practice in taking care of respiratory distress in
prematurely born infants.
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Abbreviations
BPD Bronchopulmonary dysplasia
EEV End-expiratory lung volume
GA Gestational age
HHFNC Humidified high-flow nasal cannula
INSURE Intubation Surfactant Extubation
nCPAP Nasally delivered continuous positive airway
pressure
nIPPV Nasal intermittent positive pressure ventilation
NIV Noninvasive ventilation
PEEP Positive-end expiratory pressure
PIP Peak inspiratory pressure
SIMV Synchronized intermittent mandatory
ventilation
Surfactant Surface active agent
Introduction
One of the most critical events in life is the switch from
dependence on placental gas exchange in utero to air
breathing at birth. In utero several processes take place to
ensure an effective transition. However, full respiratory
adaptation to extra uterine life takes weeks to complete. The
primary function of the lungs is to arterialize mixed venous
blood. This is achieved by pulmonary gas exchange and
involves three important processes: ventilation, diffusion,
and perfusion. When the newborn child is suffering from an
incomplete transition due to, e.g., asphyxia, persistent
pulmonary hypertension, infection, or prematurity, acute
respiratory problems develop soon after birth. Pulmonary
disorders represent one the most common diagnoses in
infants admitted to neonatal units. In the previous decades,
it was common practice to start endotracheal intubation and
J. P. de Winter (*): M. A. G. de Vries
Department of Pediatrics, Spaarne Hospital,
Hoofddorp, The Netherlands
e-mail: pdewinter@spaarneziekenhuis.nl
L. J. I. Zimmermann
Department of Pediatrics,
Research School Oncology and Developmental Biology-grow,
Maastricht University Medical Hospital,
Maastricht, The Netherlands
Eur J Pediatr (2010) 169:777–782
DOI 10.1007/s00431-010-1159-xmechanical ventilation in case of moderate to severe
respiratory distress. Nowadays, it is well known that these
lifesaving actions may lead to adverse effects on the
respiratory system. For example, there is a risk for
bronchopulmonary dysplasia (BPD) to develop. The path-
ogenesis of BPD is mainly linked to the use of mechanical
ventilation in the immature lung [5]. The main factor
underlying chronic lung disease of the newborn is imma-
turity of the respiratory system. Other factors involved in
the development of BPD are related to changes in delivered
volume (volutrauma), delivered pressure (barotrauma), and
intubation (endotrauma) [20, 24]. The aspect of traumatic
exposure related to increased risk of airway colonization
and infection with pathogens after intubation (biotrauma) is
becoming more relevant. Although there is little evidence to
support the hypothesis that prevention of intubation
decreases the incidence of BPD, it is widely accepted that
when endotracheal intubation is required, it should be as
brief as possible [14]. Minimizing lung injury could lower
the incidence of BPD. New modern aspects show that
trauma to the respiratory system can be prevented by
starting gentle respiratory support as soon as possible after
birth. The ultimate objective of non-intubated or noninva-
sive ventilation (NIV) is to prevent intubations and invasive
mechanical ventilation [8, 11, 12, 14, 15, 28] (Table 1). In
the past years, improvements in sensors and flow delivery
systems have resulted in the introduction of a variety of
other types of NIV in addition to well-known nasal CPAP.
For the best possible application of these innovations, a
thorough physiological knowledge of the mechanism of the
respiratory system in the newborn is a must [15]. This will
be explained below. Furthermore, the modern insights of
noninvasive respiratory therapy in newborns are being
discussed in this general overview.
Physiological background of noninvasive ventilation
Lung volume depends largely on two important mechanical
units: the resistive and the elastic properties of the
respiratory system (lungs and airways). Compliance multi-
plied by resistance results in a factor called time constant,
the rate by which the respiratory system fills and/or
empties. High resistance and/or high compliance result in
a long time constant; it takes longer before the lung is
completely filled and/or emptied. The finally achieved
balance between compliance of the lungs and the chest
determines the static lung volume of the lung.
Postnatal lung compliance depends on the presence of an
alveolar lining layer with properties that permit a decrease
in surface tension at end-expiration and an increase in
surface tension on lung expansion. This surface active
agent (surfactant) prevents atelectasis at the end of
expiration and confers mechanical stability on the alveolar
structure. Almost all neonatal respiratory distress disorders
are related to the disruption of the surfactant monolayer in a
quantitative and/or qualitative manner.
The newborn child has a major disadvantage due to the
high compliance of the chest resulting in an abnormal low
volume resulting in a low oxygen store. Every clinician
should be aware of the neonate’s reflexes in order to gain
the optimal end-expiratory volume (EEV), even more in
case of prematurity. Extreme low gestational age neonates
are born at the end of the canicular and beginning of the
saccular stage of lung development. The saccules have a
reduced gas exchange surface. Together with the poor
presence of the type-II alveolar cells, the extreme compliant
thorax, and the lack of surfactant results in a limited
thoracic expansion. Also, the elasticity is reduced, and the
establishment of functional residual capacity may be
hindered. Alveolar collapse (atelectasis) during expiration
can be provoked [32].
The newborn child applies three mechanisms to adjust
for alveolar collapse: post-inspiratory diaphragmatic muscle
activity (during the expiration, the inspiratory muscle tone
persists, Fig. 1), premature inspiration (initiation of inspi-
ration before the end of expiration, Fig. 1), and laryngeal
adduction during expiration (increase resistance). The last
Table 1 Noninvasive or non-intubated ventilation in newborns
Delivery room; Neopuff®
Non-cycled respiratory support
Low-flow therapy (<2 L/min)
High-flow therapy (>2 L/min)
nCPAP; conventional and modern
Cycled respiratory support
Noninvasive nasopharyngeal positive pressure ventilation
nCPAP nasal continuous positive airway pressure
Fig. 1 Electromyography tracings of the diaphragm obtained from
surface electrodes and mouth pressure in a 1-day-old healthy newborn.
Arrow A points to post-inspiratory diaphragm activity at the start of
expiration. Arrow B points to the early start of the next inspiration
(insp) at the end of the same expiration (exp)
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resulting in a higher EEV.
An important aspect of noninvasive ventilation in the
newborn is preventing failure of expiratory braking and,
therefore, respiratory failure. This can be reached by giving
enough oxygen for the strenuous task of respiratory muscles
and/or enough positive-end expiratory pressures (PEEP) to
overcome respiratory braking. NIV stabilizes the respiratory
systemandshouldpreventacollapseoftherespiratorysystem.
Delivery room respiratory support
The optimal neonatal respiratory support starts immediately
after birth. Depending on the vital condition of the newborn
during the resuscitation period, maximal effort should be
made to minimize damage to the fragile respiratory system.
The rather old fashioned but still practiced technique of
neonatal resuscitation consists of using 100% cold and dry
oxygen delivered with devices that provide variable and
unmeasured volumes and pressures. This procedure may
damage the premature lung [3, 16, 29]. At birth, the lungs
are filled with fluid, and aeration must occur to establish
lung volume. Current guidelines advocate the use of
positive pressure ventilation for newborns with inadequate
or gasping respirations with or without associated brady-
cardia [16, 17]. The use of self-inflating and flow-inflating
bags is extensively described. All devices should deliver
peak inspiratory pressure (PIP) and PEEP, measured by
means of a barometer in the circuit. Initially, the first five
breaths should be sustained with slow and prolonged
inflations. The widespread use of T pieces attached to the
face mask or tube is much easier to use especially by
inexperienced operators. The Neopuff® Infant Resuscitator
is a modified T piece with an adjustable PEEP valve and
PIP control. The PEEP is constantly present in the system,
and the PIP is delivered by manual occlusions at the T
piece. Unfortunately, no clinical trials have yet shown the
superiority of this T-piece resuscitation [32]. Theoretically,
this system produces more stable pressure waves and more
regular cycles. Some anxiety remains whether a higher tidal
volume might cause volutrauma in the smallest newborns
[3, 4, 15].
It has been demonstrated that neonates who receive
sustained inflations followed by early nasally delivered
continuous positive airway pressure (nCPAP) through a
nasopharyngeal tube and started in the delivery room
had shorter ventilatory support times and less need for
intubation and surfactant [26–28]. The most important
factors which seem to prevent pulmonary sequelae are fine
tuning the start of the ventilatory support and the PEEP
pressures delivered during the procedure (approximately
5c mH 2O) [16, 17, 29]. Early administration of surfactant
during a brief intubation and an immediate extubation
followed by nCPAP has shown to be successful. This
Danish technique called Intubation Surfactant Extubation
(INSURE) significantly reduces the need for mechanical
ventilation,air leaks, and probablyBPD [9, 17, 18, 20, 28].
Nowadays, this technique is rarely used in the delivery
rooms but mostly at the NICU.
nCPAP: conventional and modern
The non-intubated application of continuous pressure
throughout the whole respiratory cycle (nCPAP) can be
provided by several different techniques ranging from a
simple bubble system (conventional nCPAP) to sophisti-
cated (modern nCPAP) mechanical systems. nCPAP
pressure is generated by two possible mechanisms: varying
the flow rate or providing a constant flow and varying
pressure by other mechanisms. Bubble CPAP is characterized
by variations in the pressure generated by rapid gas bubbling
underwater. Currently, there are no studies which compare the
different devices and show a better clinical outcome of the
modernsystems.OptimalandeffectiveuseofnCPAPrequires
team effort and experience with the chosen device. To
maintain an infant on nCPAP demands more nursing time
and knowledge of the mechanism than keeping the child on a
mechanical ventilator [5, 7, 9, 11, 15, 19, 23].
The application of positive pressure results in a number
of important physiological benefits, including stabilization
of the airways, increased lung volume, decreased airway
resistance, and breathing work [2, 4] (Table 2). However,
with excessive PEEP levels PaCO2 may increase as tidal
volume decreases and dead space increases. The increased
lung volume will also reduce lung compliance and cause a
potential problem: air leak syndromes. Pediatricians should
also be aware of depressed cardiac output caused by an
increasingintrathoracic pressure. Furthermore,several reports
have shown that the CPAP devices may produce skin
excoriation and nasal damage [9, 11].
nCPAP has been tested not only in several trials as an
alternative to mechanical ventilation for respiratory failure
but also in prophylactic studies with or without surfactant
treatment [5, 14]. Some studies suggest that surfactant
replacement therapy coupled with nCPAP in the early stage
of RDS is more effective than nCPAP alone.
Since the original work [18], nCPAP has been primarily
used to treat premature infants with RDS. Several aspects in
respiratory handling of these infants have been investigated:
treating RDS, prevention of extubation failure, and treating
apnoea. In the treatment of RDS, nCPAP has become a
popular alternative for intubation and ventilation.
Early treatment with nCPAP could induce development
of alveoli and restore long volume, thus preventing
Eur J Pediatr (2010) 169:777–782 779mechanical intubation [8]. nCPAP delivered by binasal
prongs is more effective than single prongs and can prevent
post-extubation failure. The optimum pressure that should
be used is under study, but for nCPAP pressures between 5
and7cmH2O probably represent a reasonable range [14, 25].
Studies at early nCPAP showed significantly lower
incidence of BPD in the follow-up of very low birth weight
neonates after a gestational age of 25 weeks [3, 27]. Using
the INSURE technique followed by nCPAP for moderate or
severe RDS improves the oxygenation and reduces the need
for mechanical ventilation [23].
Presently, more state-of-the-art ventilators are available
that not only can produce a stable PEEP level but also
deliver PIP values for the delivering of nasal intermittent
pressures. The future might bring aerosolized surfactants
that might help to prevent INSURE procedures and show
therapeutic effects on the respiratory system without
causing trauma [6, 22]. To date, only a few small clinical
studies in this interesting field have been performed [22].
More studies are needed to confirm the dose, particle size,
and the best delivery system and to invent the right
surfactant formulation that maintains its activity once
aerosolized.
High-flow therapy
Flow delivered to the newborn by means of nasal cannula
has been used for several decades. Until the development of
modern devices, the provision of nasal cannula gas at a
flow rate of more than about 2 l/min and the humidification
of the air were not recommended in newborns [21]. Both
recommendations were based on very limited evidence.
A new technique already in use for adults was introduced:
humidified high-flow nasal cannula (HHFNC). HHFNC
therapy in adults is nowadays widely used and increasingly
popular in the USA. One of the most used definitions for
HHFNC in neonates is that humidified and optimally
warmed respiratory gases are given by nasal cannula at flow
rates between 2 and 8 L/min [13]. Theoretically, HHFNC
should prevent airway water loss, airway cooling, thickened
secretions, and nasal irritation [10, 13]. The interface is
lighter and easier to apply and might lessen nasal septal
damage compared with the CPAP systems. The theoretical
aspects have been tested in the laboratory; trials have shown
neither positive nor negative effects on the newborn
respiratory system. It has been shown that HHFNC indeed
produces some kind of positive airway pressure. Before
introducing HHFNC on neonatal wards and even before
startingrandomizedtrials,thereareseveralobstaclesthathave
to be taken; the PEEP pressure is very variable and relatively
unpredictable. Besides that, the positive airway pressure is
unregulated. Clinical effects and/or changes in pulmonary
function should be measured carefully.
Noninvasive intermittent positive pressure ventilation
Nasal intermittent positive pressure ventilation (nIPPV)
is another approach of noninvasive respiratory assistance
combining nCPAP with superimposed ventilator breaths.
With this mode, the nasal intermittent positive pressure
ventilation is given via nasal prongs and, therefore,
creates intermittently elevated pharyngeal pressures.
Theoretically, this may improve the patency of the
upper airway [1, 20]. By initiating inspiratory reflexes,
the respiratory drive is activated [4, 30]. It was concluded
that nIPPV for optimal support remains a complicated art
[4]. Furthermore, research showed that, compared to
nCPAP, the addition of ventilator delivered PIP decreased
the work of breathing in premature infants [1, 2]. When
the nIPPV is synchronized, tidal and minute volumes are
improved what makes nIPPV preferable to nCPAP alone
[23]. A recent meta-analysis showed the superiority of
nIPPV to nCPAP in preventing extubation failure [5].
Lower incidence of BPD in preterm infants treated with
nIPPV is seen, but not significantly proven yet. Current
studies are focused on preterm infants treated with
surfactant for RDS, to determine whether rapid extubation
to nIPPV would be a more successful approach than
continued endotracheal SIMV [25]. Although nIPPV is
emerging as an effective noninvasive alternative for the
treatment of RDS, controlled studies have not yet been
published [31].
Improved respiratory mechanics Increased lung volume
Increased compliance
Decreased resistance
Improved respiratory timing Decreased thoracoabdominal asynchrony
Decreased obstructive and mixed apnoea
Improved respiratory timing
Improved oxygenation Decreased pulmonary vascular resistance
Decreased intrapulmonary shunting
Increased alveolar volume and less collapse
Table 2 Beneficial effects of
noninvasive ventilation in
newborns
780 Eur J Pediatr (2010) 169:777–782Example of an algorithm for the noninvasive treatment
of RDS in prematurely born infants
Hundreds of studies have discussed the (dis)advantages
of more than a dozen different techniques in optimal
respiratory management of premature infants from the
first minutes of life up to several days. The conclusion
is that the optimal strategy is related to the gestational
age. The premature infant below 28 weeks of gestation-
al age probably needs more prophylactic treatments like
CPAP and surfactant. In the Netherlands, the policy is
that all infants below 32 weeks of gestational age are
transported in utero to one of eight neonatal intensive
care units. Nasal flow and nCPAP can be started in
infants born after 32 weeks of gestational age, depend-
i n go nt h es e v e r i t yo fR D S ,a n dc a nb ec o n t i n u e di nt h e
majority of the general hospitals. A potential algorithm
is displayed in Fig. 2.I ti sc o m m o np r a c t i c et os t a r tl o w
flow followed by nCPAP in premature infants born after
32 weeks of gestational age. If RDS worsens, PEEP level
is increased in order to obtain a FiO2 below 0.4. With
increasing respiratory distress, intubation is started, and if
needed, surfactant is given after transportation to a
neonatal intensive care unit. Usually, nCPAP is started
very soon or even immediately after birth in infants born
before 32 weeks. Depending on the severity of respiratory
distress, intubation and extubation is performed within
1 day. The INSURE procedure can only be applied to the
smallest premature infants born at a neonatal intensive
care unit in university hospitals. The experience depends
largely on locally available conditions.
Practical conclusions
NIV is a modern instrument for the pediatrician and is
nowadays widely available. With increasing availability of
instruments, the scientific evidence is unfortunately decreasing.
Several methods need a thorough research before application in
newborn children can be justified. nCPAP and nIPPV are not
without important risks. HHFNC needs a thorough investiga-
t i o nb e f o r et h i st y p eo fN I Vc a nb ea p p l i e di nt r i a l s .
Important practical conclusions for applying NIV in
newborns with respiratory distress:
& A physiological background is needed to understand
NIV
& NIV can be used to avoid mechanical ventilation
& Adjustable and measured PEEP should be used imme-
diately after birth
& PEEP levels should remain around +5 cm H2Oo r
higher
& nCPAP appears to be a satisfactory alternative to
endotracheal intubation
& Without available scientific evidence, it seems poten-
tially harmful to use HHFNC in newborns.
Fig. 2 Proposed algorithm for the treatment of RDS using noninva-
sive ventilation in premature infants with increasing respiratory
distress syndrome. GA gestational age; INSURE Intubation Surfactant
Extubation; nCPAP nasally delivered continuous positive airway
pressure; nIPPV nasal intermittent positive pressure ventilation; SIMV
synchronized intermittent mandatory ventilation
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